These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22210429)

  • 1. Pulmonary embolism and reactivation of tuberculosis during everolimus therapy in a kidney transplant recipient.
    Fijałkowska-Morawska JB; Jagodzińska M; Nowicki M
    Ann Transplant; 2011; 16(4):107-10. PubMed ID: 22210429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early everolimus-induced pneumonitis in a renal transplant recipient: A case report.
    Sułkowska K; Palczewski P; Miszewska-Szyszkowska D; Durlik M; Gołębiowski M; Małkowski P
    Ann Transplant; 2012 Dec; 17(4):144-8. PubMed ID: 23274336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Everolimus-induced lymphedema in a renal transplant recipient: a case report.
    Ersoy A; Koca N
    Exp Clin Transplant; 2012 Jun; 10(3):296-8. PubMed ID: 22631070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe everolimus-associated pneumonitis in a renal transplant recipient.
    Alexandru S; Ortiz A; Baldovi S; Milicua JM; Ruíz-Escribano E; Egido J; Plaza JJ
    Nephrol Dial Transplant; 2008 Oct; 23(10):3353-5. PubMed ID: 18658177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late Pulmonary Toxicity Associated With Everolimus in a Renal Transplant Patient and Review of the Literature.
    Velioglu A; Eryuksel E; Cimsit C; Tuglular S; Ozener C
    Exp Clin Transplant; 2018 Aug; 16(4):491-494. PubMed ID: 27001620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Worsening pneumonitis due to a pharmacokinetic drug-drug interaction between everolimus and voriconazole in a renal transplant patient.
    Lecefel C; Eloy P; Chauvin B; Wyplosz B; Amilien V; Massias L; Taburet AM; Francois H; Furlan V
    J Clin Pharm Ther; 2015 Feb; 40(1):119-20. PubMed ID: 25417855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial.
    Nashan B; Schemmer P; Braun F; Dworak M; Wimmer P; Schlitt H
    Trials; 2015 Mar; 16():118. PubMed ID: 25873064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two cases of everolimus-associated interstitial pneumonia in patients with renal cell carcinoma.
    Akata K; Yatera K; Ishimoto H; Kozaki M; Yamasaki K; Nagata S; Nishida C; Yoshida T; Kawanami T; Matsumoto T; Mukae H
    Intern Med; 2011; 50(24):3013-7. PubMed ID: 22185995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Everolimus-related pulmonary toxicity in heart transplant recipients.
    Expósito V; de Prada JA; Gómez-Román JJ; González-Vilchez F; Llano-Cardenal M; García-Camarero T; Fernández-Valls M; Ruano J; Martín-Durán R
    J Heart Lung Transplant; 2008 Jul; 27(7):797-800. PubMed ID: 18582812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of rifamycins-everolimus drug-drug interactions in a liver-transplant patient with pulmonary tuberculosis.
    Lefeuvre S; Rebaudet S; Billaud EM; Wyplosz B
    Transpl Int; 2012 Nov; 25(11):e120-3. PubMed ID: 22994607
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of pneumocystis pneumonia associated with everolimus therapy for renal cell carcinoma.
    Saito Y; Nagayama M; Miura Y; Ogushi S; Suzuki Y; Noro R; Minegishi Y; Kimura G; Kondo Y; Gemma A
    Jpn J Clin Oncol; 2013 May; 43(5):559-62. PubMed ID: 23423809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful maternal and fetal outcome in a kidney transplant patient with everolimus exposure throughout pregnancy: a case report.
    Margoles HR; Gomez-Lobo V; Veis JH; Sherman MJ; Moore J
    Transplant Proc; 2014; 46(1):281-3. PubMed ID: 24507068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial.
    Favi E; Spagnoletti G; Salerno MP; Pedroso JA; Romagnoli J; Citterio F
    Clin Transplant; 2013; 27(4):E359-67. PubMed ID: 23710603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal acute pulmonary injury associated with everolimus.
    Depuydt P; Nollet J; Benoit D; Praet M; Caes F
    Ann Pharmacother; 2012 Mar; 46(3):e7. PubMed ID: 22333263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse alveolar hemorrhage induced by everolimus.
    Vandewiele B; Vandecasteele SJ; Vanwalleghem L; De Vriese AS
    Chest; 2010 Feb; 137(2):456-9. PubMed ID: 20133293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombotic thrombocytopenic purpura associated with everolimus use in a renal transplant patient.
    Yılmaz VT; Koçak H; Avcı AB; Salim O; Ersoy FF; Süleymanlar G
    Int Urol Nephrol; 2011 Jun; 43(2):581-4. PubMed ID: 20495869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteinuria associated with mTOR inhibitors after kidney transplant.
    Guney M; Sahin G; Yilmaz B; Canbakan M; Gucun M; Kayatas K; Eren P; Titiz I
    Exp Clin Transplant; 2014 Dec; 12(6):539-42. PubMed ID: 25489805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion to everolimus in a patient with arterial hypertension and recurrent cutaneous neoplasia--a case report.
    Pascual J; Fernández AM; Marcén R; Ortuño J
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii38-41. PubMed ID: 16815857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-renal transplant hemolytic uremic syndrome following combination therapy with tacrolimus and everolimus.
    Pratap B; Abraham G; Srinivas CN; Bhaskar S
    Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):609-12. PubMed ID: 17951952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.